Propelling Inhalation Forward

Discover More

Next Generation Of Low CO2 Footprint Inhalers - How Can We Manage The Transition Together?
Chris Baron and Segolene Sarrailh
Aptar Pharma
HFA-152a From The Laboratory To Commercial Production – A Practical Guide
Stuart Corr and Paul Watkinson
Koura
Greening Up Our Act To Secure Supply: Supporting Pharma To Move Towards More Environmentally Friendly Propellants
Lei Mao and Mark Knowles
Recipharm
Using The Plateau-Rayleigh Instability To Produce HFA152a Droplets
Harry Scott
Monash University
Stressed And Accelerated Storage Of Pressurized Metered Dose Inhalers With Various Valve Types To Explore The Impact On Aerosol Performance Characteristics And Product Quality Attributes
Irene Rossi
Nanopharm, an Aptar Pharma Company
Predicting The Regional Deposition And Systemic Exposure Of Albuterol Sulfate Formulated With Low Global Warming Potential Propellants
Will Ganley
Nanopharm, an Aptar Pharma Company
Pairwise Analysis Of The Effect Of Clinically Relevant Conditions On The Fine Particle Dose Of Bronchodilator From Metered Dose Inhaler With Valved Holding Chamber Combinations
Lois Slator
Philips Respironics
A Comparison, Using Functional Respiratory Imaging (FRI), Of Adult Airway Deposition Profiles From a pMDI With Valved Holding Chamber (pMDI/VHC) And Two DPIs
Jason Suggett
Trudell Medical International
Factors Influencing Plume Characteristics Of MDIs Following Passage Through Bio-relevant Mouth-throat Models
Sneha Dhapare
U.S. Food & Drug Administration
AS
Modeling Specific Crystal Faces Of Solid Particles In MDI Formulations
Vivian Barron and Alex Slowey
University of Leeds
CO-ORGANIZERS
CONFERENCE SUPPORTERS
WORKSHOP PRESENTERS
EXHIBITORS
MEDIA PARTNERS

Exhibitors

↑ Back to Top